SJSimerjot Kaur Jassal

Simerjot Kaur Jassal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Simerjot Kaur Jassal has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Denise von Mühlen

    Division of Epidemiology, Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA

    5 shared publications
  • Elizabeth Barrett-Connor

    University of California, San Diego

    5 shared publications
  • Elizabeth Barrett-Connor

    Division of Epidemiology, Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, California

    4 shared publications
  • Donna Kritz-Silverstein

    2 shared publications
  • Gail A. Laughlin

    Division of Epidemiology, Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, California

    2 shared publications
  • Joachim H. Ix

    Division of Epidemiology, Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, California; Division of Nephrology, Department of Medicine, University of California, San Diego, La Jolla, California; Section of Nephrology, Medicine Service, VA San Diego Healthcare System, San Diego, California

    2 shared publications

Latest Publications

  • Urine Creatinine–Based Estimates of Fat-Free Mass in Community-Dwelling Older Persons: The Rancho Bernardo Study

    by Simerjot K. Jassal, Christina L. Wassel, Gail A. Laughlin, Elizabeth Barrett-Connor, Dena E. Rifkin, Joachim H. Ix


  • Kidney Function and Progression of Coronary Artery Calcium in Community-Dwelling Older Adults (from the Rancho Bernardo Study)

    by Simerjot Kaur Jassal, Michel Chonchol, Gail A. Laughlin, Kevin M. Cummins, Gerard Smits, Caroline K. Kramer, Joachim H. Ix, Elizabeth Barrett-Connor


  • Vitamin D, Parathyroid Hormone, and Cardiovascular Mortality in Older Adults: The Rancho Bernardo Study

    by Simerjot K. Jassal, Michel Chonchol, Denise von Mühlen, Gerard Smits, Elizabeth Barrett-Connor


  • Open Access

    Jassal et al. Respond to “Microalbuminuria and Brain Vascular Disease”

    by Simerjot K. Jassal, Donna Kritz-Silverstein, Elizabeth Barrett-Connor


  • Open Access

    A Prospective Study of Albuminuria and Cognitive Function in Older Adults: The Rancho Bernardo Study

    by Simerjot K. Jassal, Donna Kritz-Silverstein, Elizabeth Barrett-Connor

    Chronic kidney disease is a risk factor for cognitive impairment. Albuminuria is an early manifestation of chronic kidney disease and a marker of endothelial dysfunction and vascular risk. Results of prior studies of albuminuria and cognitive function are contradictory. The authors studied 1,345 community-dwelling women and men in southern California (mean age, 75 years) at a 1992–1996 research clinic visit, when urine albumin/creatinine ratio (ACR) was measured in spot morning urine and cognitive function was evaluated by using the Mini-Mental State Examination Trail-Making Test B, and category fluency test. An ACR of ≥30 mg/g was found in 17% of women and 15% of men in 1992–1996. Analysis of covariance was used to compare cognitive function score by categorical ACR. Between 1999 and 2002, 759 participants returned for repeat cognitive function testing. For men, but not women, baseline albuminuria, but not estimated glomerular filtration rate, was associated with reduced cognitive function at follow-up on all tests (P's < 0.05). An ACR of ≥30 mg/g was associated with greater annual decline in Mini-Mental State Examination and category fluency scores. Albuminuria may be an easily measured marker predicting future cognitive function decline. Results imply a common underlying mechanism affecting the renal and cerebral microvasculature.


  • Open Access

    Peripheral arterial disease and osteoporosis in older adults: the Rancho Bernardo Study

    by D. von Mühlen, M. Allison, S. K. Jassal, E. Barrett-Connor

    Summary We examined the association between peripheral arterial disease (PAD) and bone health in 1,332 adults. We found a weak association between PAD and osteoporosis and bone loss only in women, but the association was not independent of age. PAD was not associated with fractures in this community-based population. Introduction Increased rates of osteoporosis have been reported in patients with cardiovascular disease, suggesting a link between osteoporosis and atherosclerosis. Methods We examined the association between PAD and bone health in 1,332 adults who attended a research visit in 1992–1996, when the ankle–brachial index (ABI), bone mineral density (BMD), and spine X-rays were obtained. A total of 837 participants attended a follow-up visit in 1997–2000. Results PAD defined by an ABI ≤ 0.90 was present in 15.4% of the women and 13.3% of the men. Prevalence of osteoporosis was significantly higher in women with PAD compared to women without PAD (p < 0.05). During an average 4-year follow-up, women with PAD had a significantly higher rate of bone loss than women without PAD (p = 0.05). The associations were no longer significant after age adjustment. In men, PAD was not associated with osteoporosis, but men with PAD had lower BMD at the femoral neck than men without PAD (p = 0.03). PAD was not associated with osteoporotic fractures in either sex. Conclusion We found a weak and age-dependent association between PAD and osteoporosis in women but not men. PAD was not associated with fractures in this community-based population.


  • Open Access

    Measures of Renal Function, BMD, Bone Loss, and Osteoporotic Fracture in Older Adults: The Rancho Bernardo Study

    by Simerjot K Jassal, Denise von Muhlen, Elizabeth Barrett-Connor

    The association between bone and renal function in healthy seniors is not well studied. In this cross‐sectional and longitudinal study in 1713 older men and women, creatinine clearance was significantly associated with hip BMD. If confirmed, this may warrant adding mild to moderate renal dysfunction as an indication for osteoporosis screening. Introduction: This study determined the cross‐sectional and longitudinal association between measures of renal function and BMD, bone loss, and osteoporotic fracture in older adults. It determined which measure of renal function'creatinine clearance by the Cockcroft‐Gault (CG) equation, estimated glomerular filtration rate by the Modification of Diet in Renal Disease (MDRD) equation, or serum creatinine'is most strongly associated with BMD and osteoporotic fracture. Materials and Methods: This was a cross‐sectional and prospective study in older community‐dwelling men and women. Between 1992 and 1995, 1713 participants (average age, 71.3 ± 11.1 years) completed standardized questionnaires, physical examinations, laboratory testing, and bone densitometry; 1023 participants returned for a follow‐up visit in 1997–1999, an average of 4.1 ± 0.9 years later. Results: Calculated renal function declined with age (p < 0.001). Renal function was categorized by Kidney Disease Outcomes Quality Initiative (K/DOQI) chronic kidney disease (CKD) stage. By the CG equation, at baseline, 5.5% of participants had stage 1 CKD (glomerular filtration rate ≤ 90 ml/min/1.73 m2), 43.0% had stage 2 CKD (60–89 ml/min/1.73 m2), 48.8% had stage 3 CKD (30–59 ml/min/1.73 m2), and 2.7% had stages 4 and 5 CKD (2). Using the MDRD equation, these percents were 7.0%, 61.7%, 30.9%, and 0.5%, respectively. In cross‐sectional analyses, there was a significant linear association between creatinine clearance by CG or glomerular filtration rate by MDRD and hip BMD. In prospective analyses, there was an average annual bone loss of 0.6% and a significant association between baseline CG and 4‐year hip bone loss. There was no association between baseline MDRD or serum creatinine and bone loss. At baseline, 180 of 1713 participants (11%) reported at least one clinical fracture of the hip, femur, forearm, or wrist; 79 (8%) reported new clinical fractures during follow‐up. Baseline renal function by any measure was not significantly associated with prevalent or incident clinical fractures. Conclusions: Although renal function measured by both CG and MDRD was associated with BMD in cross‐sectional analyses, only creatinine clearance by CG predicted 4‐year bone loss. If confirmed, this should be the preferred method for assessing the association between renal function and BMD. Cross‐sectional associations between renal function and BMD were strongest at higher CKD stage. None of the baseline renal function estimates was associated with prevalent or incident fractures, perhaps reflecting the multifactorial etiology of fractures beyond BMD. If further studies in the elderly confirm renal function as an important predictor of bone loss and fracture, this may warrant adding mild to moderate renal dysfunction as an indication for osteoporosis screening.


  • Serum insulin-like growth factor binding protein-1 levels and bone mineral density in older adults: The Rancho Bernardo Study

    by Simerjot K. Jassal, Denise von Muhlen, Elizabeth Barrett-Connor, Clifford J. Rosen

    Insulin-like growth factor-I (IGF-I) stimulates osteoblast function, inhibits collagen matrix degradation, and is positively associated with bone mineral density in most but not all studies. We previously reported that IGF-I was positively associated with BMD at the spine and hip in women but not men. Insulin-like growth factor binding protein-1 (IGFBP-1), a potent modulator of IGF-I, is expressed in normal osteoblasts and inhibits collagen gene expression in bone, but little is known about the relationship between IGFBP-1 and bone mineral density (BMD). We report a cross-sectional study of serum IGFBP-1 levels and BMD in 1,139 community-dwelling men and postmenopausal women (not using estrogen), aged 44–98. In both sexes, IGFBP-1 levels increased linearly with age (pp<0.001). After adjusting for age and BMI, there was no significant association between IGFBP-1 and BMD at the hip or spine. IGF-I and IGFBP-1 were weakly and inversely associated with each other. These findings suggest that if there is an important role for IGFBP-1 in bone metabolism, it is mediated or confounded by weight. Studies are needed to further investigate the relationship between inhibitory components of IGF-1 and bone loss.